T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.28% |
| 2 | Consumer Discretionary | 14.05% |
| 3 | Financials | 13.42% |
| 4 | Industrials | 12.52% |
| 5 | Technology | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XRM
1376
DELISTED
Xerium Technologies Inc (new)
XRM
| $7.97M | ﹤0.01% |
505,000
| – | – |
|
1377
Winmark
WINA
$1.26B
| $7.93M | ﹤0.01% |
91,242
+52,908
| +138% | +$4.26M |
|
1378
O-I Glass
OI
$1.05B
| $7.93M | ﹤0.01% |
293,830
+30,000
| +11% | +$771K |
|
|
SFLY
1379
DELISTED
Shutterfly, Inc.
SFLY
| $7.89M | ﹤0.01% |
189,200
-14,600
| -7% | -$622K |
|
|
SLH
1380
DELISTED
SOLERA HOLDINGS, INC. COM
SLH
| $7.85M | ﹤0.01% |
153,450
-2,600
| -2% | -$136K |
|
|
ANSS
1381
DELISTED
Ansys
ANSS
| $7.83M | ﹤0.01% |
95,499
-14,845
| -13% | -$1.18M |
|
1382
ICU Medical
ICUI
$4.58B
| $7.76M | ﹤0.01% |
94,700
+5,500
| +6% | +$422K |
|
1383
AutoNation
AN
$6.9B
| $7.73M | ﹤0.01% |
128,021
+22,020
| +21% | +$1.23M |
|
1384
Pegasystems
PEGA
$5.51B
| $7.72M | ﹤0.01% |
743,800
+129,200
| +21% | +$1.32M |
|
|
JPM.WS
1385
DELISTED
JPMorgan Chase
JPM.WS
| $7.68M | ﹤0.01% |
369,300
| – | – |
|
|
AGTC
1386
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $7.65M | ﹤0.01% |
+363,857
| New | +$7.41M |
|
|
IBTX
1387
DELISTED
Independent Bank Group, Inc.
IBTX
| $7.63M | ﹤0.01% |
195,410
+93,590
| +92% | +$4.07M |
|
1388
Ryder
R
$10.1B
| $7.63M | ﹤0.01% |
82,175
-1,100
| -1% | -$98.2K |
|
|
FCE.A
1389
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $7.62M | ﹤0.01% |
357,930
-21,100
| -6% | -$439K |
|
|
WFC.WS
1390
DELISTED
Wells Fargo & Company Ws
WFC.WS
| $7.59M | ﹤0.01% |
355,275
| – | – |
|
|
PACW
1391
DELISTED
PacWest Bancorp
PACW
| $7.53M | ﹤0.01% |
165,685
+33,000
| +25% | +$1.45M |
|
|
ADVS
1392
DELISTED
Advent Software Inc
ADVS
| $7.51M | ﹤0.01% |
245,200
-6,300
| -3% | -$201K |
|
1393
Exponent
EXPO
$3.22B
| $7.49M | ﹤0.01% |
363,216
+20,800
| +6% | +$403K |
|
|
NVDQ
1394
DELISTED
Novadaq Technologies Inc.
NVDQ
| $7.49M | ﹤0.01% |
+450,550
| New | +$6.44M |
|
|
AOI
1395
DELISTED
Alliance One International
AOI
| $7.44M | ﹤0.01% |
471,082
-17,578
| -4% | -$327K |
|
|
FCRD
1396
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $7.43M | ﹤0.01% |
632,120
-9,100
| -1% | -$115K |
|
|
NE
1397
DELISTED
Noble Corporation
NE
| $7.4M | ﹤0.01% |
446,460
+6,500
| +1% | +$124K |
|
1398
LKQ Corp
LKQ
$6.25B
| $7.35M | ﹤0.01% |
261,461
-18,378
| -7% | -$513K |
|
|
HABT
1399
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $7.35M | ﹤0.01% |
+227,100
| New | +$7.93M |
|
|
PDCO
1400
DELISTED
Patterson Companies, Inc.
PDCO
| $7.34M | ﹤0.01% |
152,624
+964
| +0.6% | +$43.4K |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.